|By Marketwired .||
|June 23, 2014 11:11 AM EDT||
SAN DIEGO, CA -- (Marketwired) -- 06/23/14 -- Intellectual dominance in life sciences has traditionally been concentrated in the key markets of Boston, California and Germany, near the multi-national corporations that drive innovation. Yet, a key market ranking -- the third annual JLL Global Life Sciences Cluster Report released today at the BIO International Convention in San Diego -- suggests that the industry may be shifting its intellectual prowess toward emerging markets and middle-market corporate players.
"The biopharmaceutical industry is undergoing a significant transition as start-ups, specialty firms and mid-tier companies become the leading source of new product innovation," said Roger Humphrey, Executive Managing Director of JLL's (NYSE: JLL) Life Sciences group in the Americas. "This shift is reflected in the changing physical landscape of biopharmaceutical operations, including real estate."
The 2014 JLL Global Life Sciences Cluster Report identifies three primary global life sciences trends:
1. Start-ups, specialty firms and mid-tier companies are beginning to lead innovation.
Following the "doom and gloom" era of patent expirations, depleted product pipelines and uncertainty in U.S. healthcare reform, 2013 brought new energy to the life sciences industry. As large pharmaceutical companies continue to retrench, small- to medium-sized companies and specialty players are steadily growing, propelling initial public offerings to a volume not seen since the "dot.com" bubble of the 2000s. In some instances, vacated facilities are being retrofitted to accommodate the growing needs of mid-tier and specialty biopharmaceutical companies seeking space and access to resources.
These trends are stimulating significant changes in biopharmaceutical facilities. In mature markets such as the United States and Western Europe, many large life sciences companies have consolidated their operations and vacated their campuses. In 2013, for example, Germany-based Boehringer Ingelheim put up for sale its 190-acre, world-class production campus in Petersburg, Va., in the southeast United States. The company cited competition from low-cost generic medicines as a factor in the decision.
2. Competition is going global: for innovation, customers and talent.
North America and Europe continue to be the dominant contributors of life sciences Patent Cooperation Treaty (PCT) applications -- but a review of year-over-year application volume by country of origin reveals dramatic global shifts in innovation. Developing countries are beginning to challenge the hegemony of more mature economies.
North America and Europe's PCT life sciences patent volume is steadily decreasing, while that of Asia, Latin America and the Caribbean is increasing. In 2012, China reported the largest year-over-year increase -- 42.8 percent -- in total number of life sciences PCT applications, a rate far outpacing the growth of its overall PCT applications. Asia's share of PCT life sciences applications grew to 26 percent in 2012 from approximately 5 percent in 1990, while North America's share shrank to 41 percent in 2012 from more than 50 percent in 1990.
"Notably, the three countries with the most year-over-year growth in overall PCT applications -- China, Korea and Japan -- are also among the least collaborative countries," notes Erin Bovee, lead researcher for JLL's Global Life Sciences Cluster Report. "These countries appear to be seeking self-sufficiency in innovation."
Emerging countries are also gaining ground in talent development. China educates only a small percentage of its population, yet long ago surpassed the United States as the frontrunner in science and engineering doctorates. The United States remains a leader in awarding higher degrees in science and engineering, but is training fewer young workers than such countries as the Netherlands, South Korea, the United Kingdom, Australia and Japan.
3. Facilities are receiving new attention as a source of cost savings and regulatory compliance.
As detailed in JLL's 2011 Global Life Sciences Cluster Report, global pharmaceutical companies acted quickly in response to the patent cliff by consolidating; reducing their facilities footprints through building sales and decommissioning; trimming labor costs through layoffs; and increasing the outsourcing of non-core services.
"The need for strategic corporate real estate portfolio planning is at an all-time high as companies of all sizes seek operating efficiencies," said Humphrey. "Globally, the changes in life sciences companies' real estate portfolios are some of the most drastic among all industries."
The industry's move to more profitable and faster growth models has led to downsizing in mature markets and a focus on opportunities in emerging markets. JLL's 2014 Global Corporate Real Estate Trends for the Life Sciences Sector found that more than a third of life sciences companies anticipate reducing or consolidating their real estate portfolios in European markets, while 63 percent and 48 percent plan to increase their portfolios in China and Brazil, respectively, and 35 percent in Russia. In 2011, for example, Pfizer opted to relocate its antibacterial research unit from the United States to Shanghai.
Beyond the site selection challenges, many companies have turned to strategic facilities management to reduce operating costs. The life sciences sector is already the most active in facilities outsourcing, according to JLL's Corporate Real Estate Trends report, with 22 percent of companies fully outsourcing portfolio and facilities management functions, compared to 13 percent in other industries.
"Life sciences companies around the world are using qualified service providers to manage not only building systems, but also laboratory and production equipment, hazardous waste, supply chain and other critical areas like facilities regulatory compliance," said Dr. Lee Elliott, Head of EMEA Research for JLL. "We expect facilities outsourcing to continue to extend into highly-regulated spaces that, in the past, were off-limits."
About the Global Life Sciences Cluster Report
JLL's annual Global Life Sciences Cluster Report tracks geographic shifts in life sciences innovation, operations and facilities investments, including a ranking of the top U.S. life sciences clusters and analyses of countries and cities around the world most actively investing in life sciences. The complete findings of the 2014 Global Life Sciences Cluster Report are available here.
About JLL's Life Sciences Capabilities
JLL offers a team of real estate and facility management experts dedicated to helping life sciences companies optimize and manage their real estate portfolios. The firm provides a comprehensive range of services with singular technical operations and GxP expertise dedicated to the Life Sciences and Pharmaceutical community with more than 70 million square feet managed of R&D/pilot plant, manufacturing and office space worldwide. Its industry-leading platform includes Labwell, a comprehensive laboratory service.
A leader in the real estate outsourcing field, JLL's Corporate Solutions business helps corporations improve productivity in the cost, efficiency and performance of their national, regional or global real estate portfolios by creating outsourcing partnerships to manage and execute a range of corporate real estate services. This service delivery capability helps corporations improve business performance, particularly as companies turn to the outsourcing of their real estate activity as a way to manage expenses and enhance profitability.
For more news, videos and research resources on JLL, please visit the firm's global media center Web page http://bit.ly/18P2tkv.
JLL (NYSE: JLL) is a professional services and investment management firm offering specialized real estate services to clients seeking increased value by owning, occupying and investing in real estate. With annual fee revenue of $4 billion, JLL has more than 200 corporate offices and operates in 75 countries worldwide. On behalf of its clients, the firm provides management and real estate outsourcing services for a property portfolio of 3 billion square feet and completed $99 billion in sales, acquisitions and finance transactions in 2013. Its investment management business, LaSalle Investment Management, has $48.0 billion of real estate assets under management. JLL is the brand name of Jones Lang LaSalle Incorporated. For further information, visit www.jll.com.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2623634
15th Cloud Expo, which took place Nov. 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA, expanded the conference content of @ThingsExpo, Big Data Expo, and DevOps Summit to include two developer events. IBM held a Bluemix Developer Playground on November 5 and ElasticBox held a Hackathon on November 6. Both events took place on the expo floor. The Bluemix Developer Playground, for developers of all levels, highlighted the ease of use of Bluemix, its services and functionalit...
Nov. 27, 2014 07:00 PM EST Reads: 1,143
"We help companies that are using a lot of Software as a Service. We help companies manage and gain visibility into what people are using inside the company and decide to secure them or use standards to lock down or to embrace the adoption of SaaS inside the company," explained Scott Kriz, Co-founder and CEO of Bitium, in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Nov. 27, 2014 07:00 PM EST Reads: 1,279
Some developers believe that monitoring is a function of the operations team. Some operations teams firmly believe that monitoring the systems they maintain is sufficient to run the business successfully. Most of them are wrong. The complexity of today's applications have gone far and beyond the capabilities of "traditional" system-level monitoring tools and approaches and requires much broader knowledge of business and applications as a whole. The goal of DevOps is to connect all aspects of app...
Nov. 27, 2014 06:00 PM EST Reads: 994
The 4th International DevOps Summit, co-located with16th International Cloud Expo – being held June 9-11, 2015, at the Javits Center in New York City, NY – announces that its Call for Papers is now open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's large...
Nov. 27, 2014 06:00 PM EST Reads: 1,693
SAP is delivering break-through innovation combined with fantastic user experience powered by the market-leading in-memory technology, SAP HANA. In his General Session at 15th Cloud Expo, Thorsten Leiduck, VP ISVs & Digital Commerce, SAP, discussed how SAP and partners provide cloud and hybrid cloud solutions as well as real-time Big Data offerings that help companies of all sizes and industries run better. SAP launched an application challenge to award the most innovative SAP HANA and SAP HANA...
Nov. 27, 2014 05:00 PM EST Reads: 1,272
When an enterprise builds a hybrid IaaS cloud connecting its data center to one or more public clouds, security is often a major topic along with the other challenges involved. Security is closely intertwined with the networking choices made for the hybrid cloud. Traditional networking approaches for building a hybrid cloud try to kludge together the enterprise infrastructure with the public cloud. Consequently this approach requires risky, deep "surgery" including changes to firewalls, subnets...
Nov. 27, 2014 04:45 PM EST Reads: 1,129
Want to enable self-service provisioning of application environments in minutes that mirror production? Can you automatically provide rich data with code-level detail back to the developers when issues occur in production? In his session at DevOps Summit, David Tesar, Microsoft Technical Evangelist on Microsoft Azure and DevOps, will discuss how to accomplish this and more utilizing technologies such as Microsoft Azure, Visual Studio online, and Application Insights in this demo-heavy session.
Nov. 27, 2014 04:45 PM EST Reads: 1,070
DevOps is all about agility. However, you don't want to be on a high-speed bus to nowhere. The right DevOps approach controls velocity with a tight feedback loop that not only consists of operational data but also incorporates business context. With a business context in the decision making, the right business priorities are incorporated, which results in a higher value creation. In his session at DevOps Summit, Todd Rader, Solutions Architect at AppDynamics, discussed key monitoring techniques...
Nov. 27, 2014 04:30 PM EST Reads: 1,129
The security devil is always in the details of the attack: the ones you've endured, the ones you prepare yourself to fend off, and the ones that, you fear, will catch you completely unaware and defenseless. The Internet of Things (IoT) is nothing if not an endless proliferation of details. It's the vision of a world in which continuous Internet connectivity and addressability is embedded into a growing range of human artifacts, into the natural world, and even into our smartphones, appliances, a...
Nov. 27, 2014 04:00 PM EST Reads: 1,592
Cultural, regulatory, environmental, political and economic (CREPE) conditions over the past decade are creating cross-industry solution spaces that require processes and technologies from both the Internet of Things (IoT), and Data Management and Analytics (DMA). These solution spaces are evolving into Sensor Analytics Ecosystems (SAE) that represent significant new opportunities for organizations of all types. Public Utilities throughout the world, providing electricity, natural gas and water,...
Nov. 27, 2014 04:00 PM EST Reads: 1,207
How do APIs and IoT relate? The answer is not as simple as merely adding an API on top of a dumb device, but rather about understanding the architectural patterns for implementing an IoT fabric. There are typically two or three trends: Exposing the device to a management framework Exposing that management framework to a business centric logic Exposing that business layer and data to end users. This last trend is the IoT stack, which involves a new shift in the separation of what stuff happe...
Nov. 27, 2014 03:00 PM EST Reads: 1,236
The 3rd International Internet of @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that its Call for Papers is now open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
Nov. 27, 2014 03:00 PM EST Reads: 860
The Internet of Things is tied together with a thin strand that is known as time. Coincidentally, at the core of nearly all data analytics is a timestamp. When working with time series data there are a few core principles that everyone should consider, especially across datasets where time is the common boundary. In his session at Internet of @ThingsExpo, Jim Scott, Director of Enterprise Strategy & Architecture at MapR Technologies, discussed single-value, geo-spatial, and log time series dat...
Nov. 27, 2014 03:00 PM EST Reads: 1,421
An entirely new security model is needed for the Internet of Things, or is it? Can we save some old and tested controls for this new and different environment? In his session at @ThingsExpo, New York's at the Javits Center, Davi Ottenheimer, EMC Senior Director of Trust, reviewed hands-on lessons with IoT devices and reveal a new risk balance you might not expect. Davi Ottenheimer, EMC Senior Director of Trust, has more than nineteen years' experience managing global security operations and asse...
Nov. 27, 2014 01:00 PM EST Reads: 1,619
The Internet of Things will greatly expand the opportunities for data collection and new business models driven off of that data. In her session at @ThingsExpo, Esmeralda Swartz, CMO of MetraTech, discussed how for this to be effective you not only need to have infrastructure and operational models capable of utilizing this new phenomenon, but increasingly service providers will need to convince a skeptical public to participate. Get ready to show them the money!
Nov. 27, 2014 11:00 AM EST Reads: 1,229